Strix Halo, AMD's upcoming and extremely large APU, has finally seen some benchmarks in 3DMark Time Spy. These early results ...
Morgan Stanley has assumed coverage of Halozyme Therapeutics (NASDAQ:HALO) with an overweight rating, citing its diversified revenue stream. The investment bank said the stock "was an alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results